SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-21-000032
Filing Date
2021-08-09
Accepted
2021-08-09 16:05:04
Documents
95
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20210630.htm   iXBRL 10-Q 2494776
2 EX-10.1 amrx-2021063010xqexx101.htm EX-10.1 21811
3 EX-31.1 amrx-2021063010xqexx311.htm EX-31.1 10237
4 EX-31.2 amrx-2021063010xqexx312.htm EX-31.2 10363
5 EX-31.3 amrx-2021063010xqexx313.htm EX-31.3 10425
6 EX-32.1 amrx-2021063010xqexx321.htm EX-32.1 5716
7 EX-32.2 amrx-2021063010xqexx322.htm EX-32.2 5662
8 EX-32.3 amrx-2021063010xqexx323.htm EX-32.3 5750
  Complete submission text file 0001723128-21-000032.txt   11765827

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20210630.xsd EX-101.SCH 81010
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20210630_cal.xml EX-101.CAL 105132
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20210630_def.xml EX-101.DEF 475639
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20210630_lab.xml EX-101.LAB 847129
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20210630_pre.xml EX-101.PRE 603474
14 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20210630_htm.xml XML 2391278
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 211156421
SIC: 2834 Pharmaceutical Preparations